In chronic sarcopenia, biomarkers associated with sarcopenia prevalence include myostatin [8], inflammatory cytokines [8], and Growth Hormone (GH)/Insulin-like Growth Factor 1 (IGF-1). This evidence concerns the gene IGF1 and sarcopenia.